Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors

Livrables

Report on Communication activities carried out

List of press releases to local and national press publication on news about the project

Report on Dissemination activities carried out

List of publications of nonconfidential results

Training reports including core scientific training and transferable skills

Description of planed scientific training and transferable skills to be carried out during the project.

Scaffold hopping and database report

Results using 3D pharmacophores programs

Report on VIRO-FLOW Schools

Description of VIROFLOW Schools and actions performed

Publications

An automated microfluidic platform for the screening and characterization of novel hepatitis B virus capsid assembly modulators

Auteurs: Tamás Vermes, Mark Kielpinski, Thomas Henkel, Miquel A. Pericàs, Esther Alza, Angelica Corcuera, Helmut Buschmann, Thomas Goldner and Andreas Urban
Publié dans: Analytical Methods, Numéro 14, 2022, Page(s) 135-146, ISSN 1759-9660
Éditeur: Royal Society of Chemistry
DOI: 10.1039/d1ay01227d

Droits de propriété intellectuelle

NOVEL INDOLIZINE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Numéro de demande/publication: 20 20061946
Date: 2020-04-29
Demandeur(s): AICURIS ANTI-INFECTIVE CURES AG

NOVEL OXALYL PIPERAZINES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)

Numéro de demande/publication: 20 20061946
Date: 2020-04-29
Demandeur(s): AICURIS ANTI-INFECTIVE CURES AG

Recherche de données OpenAIRE...

Une erreur s’est produite lors de la recherche de données OpenAIRE

Aucun résultat disponible